Minrex Resources Expands ASX Quoted Capital with 4.6 Million Shares Issued Under Agreement

Minrex Resources Strengthens Capital Base with New Share Issuance

On 27 July 2026, Minrex Resources Limited applied for the ASX quotation of 4,609,900 newly issued ordinary fully paid shares under an agreement framework. These shares were issued to bolster the company’s equity base and carry identical rights and entitlements to existing ordinary shares, ensuring equal ranking across all issued securities in this class.

The quotation process enables these shares to be traded on the ASX alongside existing ordinary shares, reflecting Minrex’s strategic decision to enhance capital structure in line with operational needs and funding strategies.

Utilization of ASX Listing Rule 7.1 Placement Capacity

The share issuance was completed without shareholder approval by leveraging Minrex’s 15% placement capacity under ASX Listing Rule 7.1. This rule permits companies to issue up to 15% of their issued capital to selected investors without convening a shareholder meeting, streamlining the capital raising process for smaller placements.

By adhering to this provision, Minrex efficiently raised capital while maintaining compliance with ASX governance standards. The company did not invoke the additional 10% placement capacity under Listing Rule 7.1A, indicating the issuance size was within the standard placement limits.

Post-Issuance Capital Structure Overview

Following the quotation of the 4,609,900 shares, Minrex’s total quoted ordinary shares will stand at 2,143,153,314. Additionally, 234,851,533 options expiring on 20 January 2030 remain quoted under ASX code MRRO, representing potential future equity dilution upon exercise.

Minrex also holds 68,500,000 unquoted performance rights (security code MRRAQ), which are contingent equity instruments subject to performance vesting conditions and currently not tradable on the ASX. This diverse capital structure supports management incentives and provides strategic flexibility.

Equal Ranking and Terms of the Newly Issued Shares

The 4,609,900 ordinary fully paid shares issued on 27 July 2026 rank equally in all respects with existing ordinary shares, ensuring holders have identical voting and economic rights. The shares were issued under an agreement, though the announcement does not disclose the counterparty or specific strategic rationale.

The shares were issued at zero monetary consideration per security, suggesting a non-cash transaction, performance-based arrangement, or other terms where economic value was not expressed as a per-share price.

Disclosure and Secondary Sale Restrictions

The shares were not offered under a disclosure document or Product Disclosure Statement, consistent with the placement’s exemption from formal prospectus requirements under Australian securities law. Minrex confirmed that any resale of these shares within 12 months will not comply with the secondary sale provisions of sections 707(3) and 1012C(6) of the Corporations Act without a cleansing notice.

This restriction may limit holders’ ability to freely trade these shares during the initial 12-month period post-issuance, and investors should seek professional advice regarding potential trading limitations.

Quoted Options and Potential Equity Dilution

Minrex’s 234,851,533 quoted options expiring on 20 January 2030 (ASX code MRRO) represent a significant contingent source of potential dilution. Exercise of these options would increase the number of ordinary shares outstanding, impacting shareholder ownership depending on exercise price and timing.

Such options are common in capital market financing, allowing companies to raise capital upfront or defer dilution until option exercise. Investors should consider this potential dilution when assessing Minrex’s future capital structure and shareholder value.

Performance Rights as Employee Incentives

The company’s 68,500,000 unquoted performance rights (security code MRRAQ) form a key part of management and employee incentive schemes. These rights vest upon meeting specific performance targets and are not currently traded on the ASX but may convert to ordinary shares if conditions are met.

This performance rights pool aligns management interests with company success while controlling dilution through performance-based vesting criteria. Investors should monitor disclosures related to vesting outcomes affecting future share counts.

Regulatory Compliance and Timing of Quotation Application

The quotation application coincided with the share issue date of 27 July 2026, adhering to ASX Listing Rule 2A requirements for prompt listing of new securities. Documentation confirms compliance with mandatory disclosure and procedural obligations under ASX rules.

This timely application facilitates liquidity and trading of the new shares upon ASX approval.

Strategic Considerations for Investors

While Minrex has not publicly detailed the strategic rationale or intended use of proceeds from this share issuance, the placement under agreement suggests a negotiated transaction rather than a broad market offer. The counterparty and specific terms remain undisclosed.

The issuance increases total share capital and dilutes existing shareholders on a fully diluted basis. Investors should evaluate this capital raise in the context of Minrex’s operational performance, cash position, and strategic plans to understand its impact on shareholder value.